NSG Ventures
Overview
NSG Ventures is a global biotech venture capital firm started and managed by scientific experts, seasoned operators, investors, and drug development professionals of successful biotech companies. Their investment focus is to back and build early-stage transformative drug discovery companies globally. Through our partnership with NSG BioLabs, Singapore's largest co-working laboratory and office space, we provide support for companies from ideation to commercialization, accelerating their growth and potential for global impact.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Protuoso Biosciences | May 2026 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Jeffrey Lu
Founding Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NSG Ventures based?
NSG Ventures is headquartered in Singapore, Central Singapore, Singapore.
When was NSG Ventures founded?
NSG Ventures was founded in 2020.
How many portfolio companies does NSG Ventures have?
NSG Ventures has 5 portfolio companies in Caplight's dataset.
What are some companies in NSG Ventures's portfolio?
Portfolio companies visible on Caplight include Protuoso Biosciences.
What was NSG Ventures's most recent investment shown here?
NSG Ventures's most recent investment in this portfolio sample was in Protuoso Biosciences in 2026.
What sectors does NSG Ventures focus on?
NSG Ventures focuses on Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.
What company stages does NSG Ventures focus on?
NSG Ventures typically invests at the Early stage.
What is NSG Ventures's AUM?
NSG Ventures's assets under management are estimated between $0.0 and $50.0M.